BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11302141)

  • 1. Fludarabine for chronic lymphocytic leukemia.
    Copur MS; Ledakis P; Muhvic J
    N Engl J Med; 2001 Apr; 344(15):1166; author reply 1167-8. PubMed ID: 11302141
    [No Abstract]   [Full Text] [Related]  

  • 2. Fludarabine for chronic lymphocytic leukemia.
    Erman M; Celik I; Tekuzman G
    N Engl J Med; 2001 Apr; 344(15):1166; author reply 1167-8. PubMed ID: 11302142
    [No Abstract]   [Full Text] [Related]  

  • 3. Fludarabine for chronic lymphocytic leukemia.
    Proctor SJ; Mounter P; Summerfield GP
    N Engl J Med; 2001 Apr; 344(15):1167; author reply 1167-8. PubMed ID: 11302143
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized phase II trial of high-dose chlorambucil vs. fludarabine in patients with advanced B-chronic lymphocytic leukemia. EORTC Leukemia Cooperative Group.
    Hematol Cell Ther; 1999 Jun; 41(3):127-36. PubMed ID: 10456443
    [No Abstract]   [Full Text] [Related]  

  • 5. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
    Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
    Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When and how to treat chronic lymphocytic leukemia.
    Dighiero G; Binet JL
    N Engl J Med; 2000 Dec; 343(24):1799-801. PubMed ID: 11114321
    [No Abstract]   [Full Text] [Related]  

  • 7. Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome.
    Abdel-Raheem MM; Jamil MG; Potti A; Gross GG
    Haematologica; 2000 Nov; 85(11):1224-5. PubMed ID: 11064479
    [No Abstract]   [Full Text] [Related]  

  • 8. Fludarabine: new indication. First-line treatment of CLL: unconvincing evidence.
    Prescrire Int; 2005 Feb; 14(75):3-5. PubMed ID: 15747447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fludarabine treatment of chronic lymphoid leukemia].
    Gabeeva NG; Pivnik AV; Moiseeva TN; Zybunova EE; Samoĭlova RS; Kremenetskaia AM; Varlamova EIu; Kaplanskaia IB
    Ter Arkh; 2000; 72(8):42-5. PubMed ID: 11019427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia.
    Lam CC; Ma ES; Kwong YL
    Am J Hematol; 2005 Aug; 79(4):288-90. PubMed ID: 16044456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fludarabine for chronic lymphocytic leukemia.
    Marchetti M; Barosi G; Liberato LN
    N Engl J Med; 2001 Apr; 344(15):1166-7; author reply 1167-8. PubMed ID: 11302140
    [No Abstract]   [Full Text] [Related]  

  • 12. Fludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia.
    Ayyildiz O; Isikdogan A; Bolaman Z; Muftuoglu E
    Saudi Med J; 2004 Dec; 25(12):2054-6. PubMed ID: 15711709
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
    Tsiara S; Christou L; Konstantinidou P; Panteli A; Briasoulis E; Bourantas KL
    Am J Hematol; 1997 Apr; 54(4):342. PubMed ID: 9092698
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
    Dizdar O; Yürekli BS; Pürnak T; Aksu S; Haznedaroglu IC
    Ann Pharmacother; 2004; 38(7-8):1319-20. PubMed ID: 15138295
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary tuberculosis after fludarabine for chronic lymphocytic leukaemia.
    Ghosh K; Sivakumaran M; Murphy P; Chapman CS
    Natl Med J India; 1995; 8(6):294-5. PubMed ID: 8520454
    [No Abstract]   [Full Text] [Related]  

  • 16. Fludarabine.
    Med Lett Drugs Ther; 1991 Sep; 33(853):89-90. PubMed ID: 1886506
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose methylprednisolone can induce remissions in patients with fludarabine-refractory chronic lymphocytic leukaemia.
    Xu W; Miao KR; Hong M; Zhu DX; Fang C; Dong HJ; Wang DM; Cao X; Li JY
    Eur J Cancer; 2010 Aug; 46(12):2145-9. PubMed ID: 20627536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia.
    Mulligan SP; Karlsson K; Strömberg M; Jønsson V; Gill D; Hammerström J; Hertzberg M; McLennan R; Uggla B; Norman J; Wallvik J; Sundström G; Johansson H; Brandberg Y; Liliemark J; Juliusson G;
    Leuk Lymphoma; 2014 Dec; 55(12):2769-77. PubMed ID: 24524339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia.
    Haines I; Elliott P; Stanley R
    Intern Med J; 2009 Apr; 39(4):269-71. PubMed ID: 19402870
    [No Abstract]   [Full Text] [Related]  

  • 20. Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?
    Ahmadi T; Schuster SJ
    J Clin Oncol; 2009 Feb; 27(4):479-80. PubMed ID: 19075263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.